Search research articles
Contact Us
Filters
Showing results (21-30 of 138) with videos related to
Page
of 14
Sort By:
Future Oncology (London, England)
|
November 18, 2022
Tremelimumab and durvalumab in the treatment of unresectable, advanced hepatocellular carcinoma
Tiago Biachi de Castria, Danny N Khalil, James J Harding, et al.
Radiology
|
February 10, 2026
How I Do It: Systemic Therapies for Primary Liver Cancers
Tae-Hyung Kim, James J Harding, Victoria Chernyak, et al.
Ocular Oncology and Pathology
|
February 20, 2024
Mitogen-Activated Pathway Kinase Inhibitor-Associated Retinopathy: Do Features Differ with Upstream versus Downstream Inhibition?
Jasmine H Francis, William Foulsham, Julia Canestraro, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 29, 2014
Cutis verticis gyrata in association with vemurafenib and whole-brain radiotherapy
James J Harding, Christopher A Barker, Richard D Carvajal, et al.
Human Immunology
|
November 24, 2004
Selective developmental defects of cord blood antigen-presenting cell subsets
Laura Drohan, James J Harding, Bari Holm, et al.
AJR. American Journal of Roentgenology
|
May 24, 2019
Aspirin Is Associated With Improved Liver Function After Embolization of Hepatocellular Carcinoma
F Edward Boas, Karen T Brown, Etay Ziv, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
October 12, 2019
Pharmacokinetic Assessment of <sup>18</sup>F-(2<i>S,</i>4<i>R</i>)-4-Fluoroglutamine in Patients with Cancer
Milan Grkovski, Reema Goel, Simone Krebs, et al.
Immunological Reviews
|
September 27, 2005
Achieving stability through editing and chaperoning: regulation of MHC class II peptide binding and expression
Robert Busch, Cornelia H Rinderknecht, Sujin Roh, et al.
Journal of Vascular and Interventional Radiology : JVIR
|
May 22, 2017
Adjuvant Medications That Improve Survival after Locoregional Therapy
F Edward Boas, Etay Ziv, Hooman Yarmohammadi, et al.
Journal of Vascular and Interventional Radiology : JVIR
|
August 27, 2017
Reply to: "Adjuvant Medications that Improve Survival after Locoregional Therapy"
F Edward Boas, Etay Ziv, Hooman Yarmohammadi, et al.
Page
of 14
Search research articles
Search
Showing results (21-30 of 138) with videos related to
Sort By:
Page
of 14
Future Oncology (London, England)
|
November 18, 2022
Tremelimumab and durvalumab in the treatment of unresectable, advanced hepatocellular carcinoma
Tiago Biachi de Castria, Danny N Khalil, James J Harding, et al.
Radiology
|
February 10, 2026
How I Do It: Systemic Therapies for Primary Liver Cancers
Tae-Hyung Kim, James J Harding, Victoria Chernyak, et al.
Ocular Oncology and Pathology
|
February 20, 2024
Mitogen-Activated Pathway Kinase Inhibitor-Associated Retinopathy: Do Features Differ with Upstream versus Downstream Inhibition?
Jasmine H Francis, William Foulsham, Julia Canestraro, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 29, 2014
Cutis verticis gyrata in association with vemurafenib and whole-brain radiotherapy
James J Harding, Christopher A Barker, Richard D Carvajal, et al.
Human Immunology
|
November 24, 2004
Selective developmental defects of cord blood antigen-presenting cell subsets
Laura Drohan, James J Harding, Bari Holm, et al.
AJR. American Journal of Roentgenology
|
May 24, 2019
Aspirin Is Associated With Improved Liver Function After Embolization of Hepatocellular Carcinoma
F Edward Boas, Karen T Brown, Etay Ziv, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
October 12, 2019
Pharmacokinetic Assessment of <sup>18</sup>F-(2<i>S,</i>4<i>R</i>)-4-Fluoroglutamine in Patients with Cancer
Milan Grkovski, Reema Goel, Simone Krebs, et al.
Immunological Reviews
|
September 27, 2005
Achieving stability through editing and chaperoning: regulation of MHC class II peptide binding and expression
Robert Busch, Cornelia H Rinderknecht, Sujin Roh, et al.
Journal of Vascular and Interventional Radiology : JVIR
|
May 22, 2017
Adjuvant Medications That Improve Survival after Locoregional Therapy
F Edward Boas, Etay Ziv, Hooman Yarmohammadi, et al.
Journal of Vascular and Interventional Radiology : JVIR
|
August 27, 2017
Reply to: "Adjuvant Medications that Improve Survival after Locoregional Therapy"
F Edward Boas, Etay Ziv, Hooman Yarmohammadi, et al.
Page
of 14